Immusoft has raised $20M in total funding. Latest round: Series B. Backed by Breakout Ventures, Alexandria Venture Investments, RBV Capital.
Immusoft funding overview
Immusoft has raised $20M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in January 2019. The round record for Immusoft runs through 2019; nothing later has been disclosed. Investors on record include Breakout Ventures, Alexandria Venture Investments, RBV Capital, DEFTA Partners, Mesa Verde Venture Partners. 5 distinct backers are named across the disclosed rounds.
Immusoft has raised $20M in total disclosed funding across the rounds on record.
Who has invested in Immusoft?
Breakout Ventures, Alexandria Venture Investments, RBV Capital, DEFTA Partners, Mesa Verde Venture Partners are named among the investors backing Immusoft.
What was the latest Immusoft funding round?
The most recent disclosed round is a Series B, announced in January 2019.
Where is Immusoft based?
No headquarters location is disclosed for Immusoft.
When did Immusoft last raise?
The last disclosed Immusoft round closed in January 2019 at Series B.
Totals shown for Immusoft aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.
